PABPN1 suppresses TDP-43 toxicity in ALS disease models

Ching Chieh Chou, Olga M. Alexeeva, Shizuka Yamada, Amy Pribadi, Yi Zhang, Bi Mo, Kathryn R. Williams, Daniela C. Zarnescu, Wilfried Rossol

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

TAR DNA-binding protein 43 (TDP-43) is a major disease protein in amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases. Both the cytoplasmic accumulation of toxic ubiquitinated and hyperphosphorylated TDP-43 fragments and the loss of normal TDP-43 from the nucleus may contribute to the disease progression by impairing normal RNA and protein homeostasis. Therefore, both the removal of pathological protein and the rescue of TDP-43 mislocalization may be critical for halting or reversing TDP-43 proteinopathies. Here, we report poly(A)-binding protein nuclear 1 (PABPN1) as a novel TDP-43 interaction partner that acts as a potent suppressor of TDP-43 toxicity. Overexpression of full-length PABPN1 but not a truncated version lacking the nuclear localization signal protects from pathogenic TDP-43-mediated toxicity, promotes the degradation of pathological TDP-43 and restores normal solubility and nuclear localization of endogenous TDP-43. Reduced levels of PABPN1 enhances the phenotypes in several cell culture and Drosophila models of ALS and results in the cytoplasmic mislocalization of TDP-43. Moreover, PABPN1 rescues the dysregulated stress granule (SG) dynamics and facilitates the removal of persistent SGs in TDP-43-mediated disease conditions. These findings demonstrate a role for PABPN1 in rescuing several cytopathological features of TDP-43 proteinopathy by increasing the turnover of pathologic proteins.

Original languageEnglish (US)
Article numberddv238
Pages (from-to)5154-5173
Number of pages20
JournalHuman Molecular Genetics
Volume24
Issue number18
DOIs
StatePublished - Apr 9 2015
Externally publishedYes

Fingerprint

Poly(A)-Binding Protein II
Amyotrophic Lateral Sclerosis
DNA-Binding Proteins
Proteins
Nuclear Localization Signals

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Chou, C. C., Alexeeva, O. M., Yamada, S., Pribadi, A., Zhang, Y., Mo, B., ... Rossol, W. (2015). PABPN1 suppresses TDP-43 toxicity in ALS disease models. Human Molecular Genetics, 24(18), 5154-5173. [ddv238]. https://doi.org/10.1093/hmg/ddv238

PABPN1 suppresses TDP-43 toxicity in ALS disease models. / Chou, Ching Chieh; Alexeeva, Olga M.; Yamada, Shizuka; Pribadi, Amy; Zhang, Yi; Mo, Bi; Williams, Kathryn R.; Zarnescu, Daniela C.; Rossol, Wilfried.

In: Human Molecular Genetics, Vol. 24, No. 18, ddv238, 09.04.2015, p. 5154-5173.

Research output: Contribution to journalArticle

Chou, CC, Alexeeva, OM, Yamada, S, Pribadi, A, Zhang, Y, Mo, B, Williams, KR, Zarnescu, DC & Rossol, W 2015, 'PABPN1 suppresses TDP-43 toxicity in ALS disease models', Human Molecular Genetics, vol. 24, no. 18, ddv238, pp. 5154-5173. https://doi.org/10.1093/hmg/ddv238
Chou CC, Alexeeva OM, Yamada S, Pribadi A, Zhang Y, Mo B et al. PABPN1 suppresses TDP-43 toxicity in ALS disease models. Human Molecular Genetics. 2015 Apr 9;24(18):5154-5173. ddv238. https://doi.org/10.1093/hmg/ddv238
Chou, Ching Chieh ; Alexeeva, Olga M. ; Yamada, Shizuka ; Pribadi, Amy ; Zhang, Yi ; Mo, Bi ; Williams, Kathryn R. ; Zarnescu, Daniela C. ; Rossol, Wilfried. / PABPN1 suppresses TDP-43 toxicity in ALS disease models. In: Human Molecular Genetics. 2015 ; Vol. 24, No. 18. pp. 5154-5173.
@article{fa07615965fe4c1cb0d177f70d97a9b2,
title = "PABPN1 suppresses TDP-43 toxicity in ALS disease models",
abstract = "TAR DNA-binding protein 43 (TDP-43) is a major disease protein in amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases. Both the cytoplasmic accumulation of toxic ubiquitinated and hyperphosphorylated TDP-43 fragments and the loss of normal TDP-43 from the nucleus may contribute to the disease progression by impairing normal RNA and protein homeostasis. Therefore, both the removal of pathological protein and the rescue of TDP-43 mislocalization may be critical for halting or reversing TDP-43 proteinopathies. Here, we report poly(A)-binding protein nuclear 1 (PABPN1) as a novel TDP-43 interaction partner that acts as a potent suppressor of TDP-43 toxicity. Overexpression of full-length PABPN1 but not a truncated version lacking the nuclear localization signal protects from pathogenic TDP-43-mediated toxicity, promotes the degradation of pathological TDP-43 and restores normal solubility and nuclear localization of endogenous TDP-43. Reduced levels of PABPN1 enhances the phenotypes in several cell culture and Drosophila models of ALS and results in the cytoplasmic mislocalization of TDP-43. Moreover, PABPN1 rescues the dysregulated stress granule (SG) dynamics and facilitates the removal of persistent SGs in TDP-43-mediated disease conditions. These findings demonstrate a role for PABPN1 in rescuing several cytopathological features of TDP-43 proteinopathy by increasing the turnover of pathologic proteins.",
author = "Chou, {Ching Chieh} and Alexeeva, {Olga M.} and Shizuka Yamada and Amy Pribadi and Yi Zhang and Bi Mo and Williams, {Kathryn R.} and Zarnescu, {Daniela C.} and Wilfried Rossol",
year = "2015",
month = "4",
day = "9",
doi = "10.1093/hmg/ddv238",
language = "English (US)",
volume = "24",
pages = "5154--5173",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "18",

}

TY - JOUR

T1 - PABPN1 suppresses TDP-43 toxicity in ALS disease models

AU - Chou, Ching Chieh

AU - Alexeeva, Olga M.

AU - Yamada, Shizuka

AU - Pribadi, Amy

AU - Zhang, Yi

AU - Mo, Bi

AU - Williams, Kathryn R.

AU - Zarnescu, Daniela C.

AU - Rossol, Wilfried

PY - 2015/4/9

Y1 - 2015/4/9

N2 - TAR DNA-binding protein 43 (TDP-43) is a major disease protein in amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases. Both the cytoplasmic accumulation of toxic ubiquitinated and hyperphosphorylated TDP-43 fragments and the loss of normal TDP-43 from the nucleus may contribute to the disease progression by impairing normal RNA and protein homeostasis. Therefore, both the removal of pathological protein and the rescue of TDP-43 mislocalization may be critical for halting or reversing TDP-43 proteinopathies. Here, we report poly(A)-binding protein nuclear 1 (PABPN1) as a novel TDP-43 interaction partner that acts as a potent suppressor of TDP-43 toxicity. Overexpression of full-length PABPN1 but not a truncated version lacking the nuclear localization signal protects from pathogenic TDP-43-mediated toxicity, promotes the degradation of pathological TDP-43 and restores normal solubility and nuclear localization of endogenous TDP-43. Reduced levels of PABPN1 enhances the phenotypes in several cell culture and Drosophila models of ALS and results in the cytoplasmic mislocalization of TDP-43. Moreover, PABPN1 rescues the dysregulated stress granule (SG) dynamics and facilitates the removal of persistent SGs in TDP-43-mediated disease conditions. These findings demonstrate a role for PABPN1 in rescuing several cytopathological features of TDP-43 proteinopathy by increasing the turnover of pathologic proteins.

AB - TAR DNA-binding protein 43 (TDP-43) is a major disease protein in amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases. Both the cytoplasmic accumulation of toxic ubiquitinated and hyperphosphorylated TDP-43 fragments and the loss of normal TDP-43 from the nucleus may contribute to the disease progression by impairing normal RNA and protein homeostasis. Therefore, both the removal of pathological protein and the rescue of TDP-43 mislocalization may be critical for halting or reversing TDP-43 proteinopathies. Here, we report poly(A)-binding protein nuclear 1 (PABPN1) as a novel TDP-43 interaction partner that acts as a potent suppressor of TDP-43 toxicity. Overexpression of full-length PABPN1 but not a truncated version lacking the nuclear localization signal protects from pathogenic TDP-43-mediated toxicity, promotes the degradation of pathological TDP-43 and restores normal solubility and nuclear localization of endogenous TDP-43. Reduced levels of PABPN1 enhances the phenotypes in several cell culture and Drosophila models of ALS and results in the cytoplasmic mislocalization of TDP-43. Moreover, PABPN1 rescues the dysregulated stress granule (SG) dynamics and facilitates the removal of persistent SGs in TDP-43-mediated disease conditions. These findings demonstrate a role for PABPN1 in rescuing several cytopathological features of TDP-43 proteinopathy by increasing the turnover of pathologic proteins.

UR - http://www.scopus.com/inward/record.url?scp=84940644746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940644746&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddv238

DO - 10.1093/hmg/ddv238

M3 - Article

VL - 24

SP - 5154

EP - 5173

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 18

M1 - ddv238

ER -